ANI Pharmaceuticals, Inc. (ANIP)
72.18
-0.78
(-1.07%)
USD |
NASDAQ |
Oct 02, 16:00
72.23
+0.05
(+0.07%)
After-Hours: 20:00
ANI Pharmaceuticals Price to Book Value : 2.776 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 2.776 |
| October 01, 2026 | 2.806 |
| September 30, 2026 | 2.794 |
| September 29, 2026 | 2.793 |
| September 28, 2026 | 2.878 |
| September 25, 2026 | 2.846 |
| September 24, 2026 | 2.848 |
| September 23, 2026 | 2.863 |
| September 22, 2026 | 2.997 |
| September 21, 2026 | 3.033 |
| September 18, 2026 | 2.929 |
| September 17, 2026 | 2.900 |
| September 16, 2026 | 2.831 |
| September 15, 2026 | 2.774 |
| September 14, 2026 | 2.708 |
| September 11, 2026 | 2.700 |
| September 10, 2026 | 2.749 |
| September 09, 2026 | 2.720 |
| September 08, 2026 | 2.702 |
| September 04, 2026 | 2.740 |
| September 03, 2026 | 2.769 |
| September 02, 2026 | 2.810 |
| September 01, 2026 | 2.766 |
| August 31, 2026 | 2.818 |
| August 28, 2026 | 2.802 |
| Date | Value |
|---|---|
| August 27, 2026 | 2.828 |
| August 26, 2026 | 2.868 |
| August 25, 2026 | 2.910 |
| August 24, 2026 | 2.853 |
| August 21, 2026 | 2.898 |
| August 20, 2026 | 2.974 |
| August 19, 2026 | 3.001 |
| August 18, 2026 | 2.957 |
| August 17, 2026 | 2.923 |
| August 14, 2026 | 2.944 |
| August 13, 2026 | 2.876 |
| August 12, 2026 | 2.889 |
| August 11, 2026 | 2.867 |
| August 10, 2026 | 2.914 |
| August 07, 2026 | 3.01 |
| August 06, 2026 | 3.178 |
| August 05, 2026 | 3.073 |
| August 04, 2026 | 3.046 |
| August 03, 2026 | 3.080 |
| July 31, 2026 | 3.048 |
| July 30, 2026 | 3.094 |
| July 29, 2026 | 3.146 |
| July 28, 2026 | 3.117 |
| July 27, 2026 | 3.015 |
| July 24, 2026 | 2.987 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ocular Therapeutix, Inc. | 2.939 |
| Liquidia Corp. | 13.08 |
| Elanco Animal Health, Inc. | 1.679 |
| Harmony Biosciences Holdings, Inc. | 2.306 |
| Corcept Therapeutics, Inc. | 17.77 |
Price to Book Value Related Metrics
| PE Ratio | 15.58 |
| PS Ratio | 1.592 |
| Price to Free Cash Flow | 9.299 |
| Price | 72.18 |
| Earnings Yield | 6.42% |
| Market Cap | 1.658B |
| Operating PE Ratio | 11.94 |
| Normalized PE Ratio | 19.81 |